Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Coronary Heart Disease

5,8,11,14-eicosatetraynoic acid has been researched along with Coronary Heart Disease in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vu-Dac, N1
Schoonjans, K1
Kosykh, V1
Dallongeville, J1
Fruchart, JC1
Staels, B1
Auwerx, J1

Trials

1 trial available for 5,8,11,14-eicosatetraynoic acid and Coronary Heart Disease

ArticleYear
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Apolipoprotein A-II; Apolipoproteins E; Base Sequence; Cells

1995